Argilés, G., Saro, J., Segal, N. H., Melero, I., Ros, W., Marabelle, A., … Tabernero, J. (2017). Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol, 28 Suppl 3, iii151. https://doi.org/10.1093/annonc/mdx302.003

Argilés, G., J. Saro, N. H. Segal, I. Melero, W. Ros, A. Marabelle, M. E. Rodriguez, et al. “Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC).” Ann Oncol 28 Suppl 3 (June 2017): iii151. https://doi.org/10.1093/annonc/mdx302.003.

Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A, et al. Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol. 2017 Jun;28 Suppl 3:iii151.

Argilés, G., et al. “Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC).” Ann Oncol, vol. 28 Suppl 3, June 2017, p. iii151. Pubmed, doi:10.1093/annonc/mdx302.003.

Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A, Rodriguez ME, Albanell J, Calvo E, Moreno V, Cleary JM, Eder P, Paz-Ares L, Hurwitz H, Bacac M, Perro M, Bouseida S, Sandoval F, Sabanes Bove D, Sreckovic S, Jamois C, Silva A, Klein C, Umana P, Karanikas V, Tabernero J. Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol. 2017 Jun;28 Suppl 3:iii151.